Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Soligenix Inc.
DescriptionAntibacterial containing active ingredient dusquetide for treatment against Burkholderia pseudomallei
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsTreat meliodosis
Regulatory Designation U.S. - Fast Track (Treat meliodosis)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today